Citation: | XU Chenshuai, WANG Fang, LI Ying, FENG Jingjing, GUO Shiwei, BAI Yujie, GUO Jianfeng. Synthesis and Drug Release Properties of pH-sensitive DOX@R9-PEC-NP for Drug Carrier[J]. Journal of North University of China(Natural Science Edition), 2023, 44(3): 286-291. |
[1] |
CHEN Y,SHI S X,DAI Y.Research progress of therapeutic drugs for doxorubicin-induced cardiomyopathy[J].Biomedicine & Pharmacotherapy,2022,156:113903.
|
[2] |
ILLY N,CORCE V,ZIMBRON J,et al.pH-sensitive poly (ethylene glycol)/poly (ethoxyethyl glycidyl ether) block copolymers:synthesis,characterization,encapsulation,and delivery of a hydrophobic drug[J].Macromolecular Chemistry and Physics,2019,220(16):1900210.
|
[3] |
FAN T T,YU X Y,SHEN B,et al.Peptide self-assembled nanostructures for drug delivery applications[J].Journal of Nanomaterials,2017(9):1-16.
|
[4] |
ROSENBLUM D,JOSHI N,TAO W,et al.Progress and challenges towards targeted delivery of cancer therapeutics[J].Nature Communications,2018,9(1):1-12.
|
[5] |
ADISESHAISAH P P,CRIST R M,HOOK S S,et al.Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer[J].Nature Reviews Clinical Oncology,2016,13(12):750-765.
|
[6] |
VALE N,DUARTE D,SILVA S,et al.Cell-penetrating peptides in oncologic pharmacotherapy:a review[J].Pharmacological Research,2020,162:105231.
|
[7] |
HAO M L,ZHANG L,CHEN P.Membrane internalization mechanisms and design strategies of arginine-rich cell-penetrating peptides[J].International Journal of Molecular Sciences,2022,23(16):9038.
|
[8] |
KELLY S H,COSSETTE B J,VARADHAN A K,et al.Titrating polyarginine into nanofibers enhances cyclic-dinucleotide adjuvanticity in vitro and after sublingual immunization[J].ACS Biomaterials Science & Engineering,2021,7(5):1876-1888.
|
[9] |
KANG S,SURESH A,KIM Y C.A highly efficient cell penetrating peptide pVEC-mediated protein delivery system into microalgae[J].Algal Research,2017,24:360-367.
|
[10] |
ZHANG N,BAN Y,ZHAO J Z,et al.Preparation and penetrating effect of the polyarginine-enhanced green fluorescence protein fusion protein[J].Chinese Journal of Biotechnology,2013,29(11):1644-1653.
|
[11] |
ZHANG L T,JIANG C G,ZENG F J,et al.A polymeric nanocarrier with a tumor acidity-activatable arginine-rich(R9) peptide for enhanced drug delivery[J].Biomaterials Science,2020,8(8):2255-2263.
|
[12] |
YANG W Z,XUE Y H ,CUI X,et al.Targeted delivery of doxorubicin to liver used a novel biotinylated β-cyclodextrin grafted pullulan nanocarrier[J].Colloids and Surfaces B:Biointerfaces,2022,220:112934.
|
[13] |
CHEN H L,NAN W B,WEI X J,et al.Toxicity,pharmacokinetics,and in vivo efficacy of biotinylated chitosan surface-modified PLGA nanoparticles for tumor therapy[J].Artificial Cells,Nanomedicine,and Biotechnology,2017,45(6):1115-1122.
|
[14] |
BOSTINCI N S,BUYUKSUNGUR S,HASIRCI N,et al.Potential of pectin for biomedical applications:a comprehensive review[J].Journal of Biomaterials Science,Polymer Edition,2022,33(14):1866-1900.
|
[15] |
GUO Y M,LI H,SHI W K,et al.Targeted delivery and pH-responsive release of doxorubicin to cancer cells using calcium carbonate/hyaluronate/glutamate mesoporous hollow spheres[J].Journal of Colloid and Interface Science,2017,502:59-66.
|
[16] |
GUO Y M,ZHANG J,JIANG L L,et al.Facile one-pot preparation of calcite mesoporous carrier for sustained and targeted drug release for cancer cells[J].Chemical Communications,2012,48(86):10636-10638.
|
[17] |
GUO Y M,FANG Q L,LI H,et al.Hollow silica nanospheres coated with insoluble calcium salts for pH-responsive sustained release of anticancer drugs[J].Chemical Communications,2016,52(70):10652-10655.
|
[18] |
CIFUTES-RIUS A,DESAI A,YUEN D,et al.Inducing immune tolerance with dendritic cell-targeting nanomedicines[J].Nature Nanotechnology,2021,16(1):37-46.
|
[19] |
ZU Y G,ZHANG Y,WANG W G,et al.Preparation and in vitro/in vivo evaluation of resveratrol-loaded carboxymethyl chitosan nanoparticles[J].Drug Delivery,2016,23(3):971-981.
|
[20] |
OUYANG J B,YANG M H,GONG T,et al.Doxorubicin-loading core-shell pectin nanocell:A novel nanovehicle for anticancer agent delivery with multidrug resistance reversal[J].PloS One,2020,15(6):e0235090.
|